Related Experiment Video
Updated: May 28, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
An Insight to Hyperhomocysteinaemia in CKD Patients of a Tertiary Care Hospital, Karachi
Nadia Yaqub1, Adnan Mustafa Zubairi, Fatima Kanani
1Department of Chemical Pathology, Indus Hospital and Health Network, Karachi, Pakistan.
Insights
Hyperhomocysteinaemia (HHcy) is highly prevalent in chronic kidney disease (CKD) patients, particularly in advanced stages. While HHcy indicates disease progression, this study found no significant association with estimated glomerular filtration rate (eGFR) stages.
Area of Science:
- Nephrology
- Clinical Chemistry
- Public Health
Background:
- Hyperhomocysteinaemia (HHcy) is a risk factor for cardiovascular disease and mortality.
- Chronic kidney disease (CKD) affects homocysteine metabolism.
- Understanding HHcy prevalence in CKD is crucial for patient management.
Purpose of the Study:
- To determine the frequency of HHcy in CKD patients across different stages.
- To investigate the association between HHcy and CKD severity.
Main Methods:
- A cross-sectional study involving 100 CKD patients.
- Estimated glomerular filtration rate (eGFR) calculated using the CKD-EPI calculator for staging.
- Plasma homocysteine (Hcy) and serum creatinine levels measured.
- Statistical analysis including Chi-square test performed.
Main Results:
- 79% of CKD patients exhibited HHcy.
- HHcy prevalence increased with CKD stage, highest in stage 5 (41.8%).
- No significant association was found between Hcy concentration and eGFR stages.
Conclusions:
- HHcy is highly prevalent in CKD patients, especially in later stages.
- Hcy may serve as a predictor of CKD progression.
- Further research and timely interventions are needed to mitigate adverse outcomes.
Objective:
To evaluate the frequency and association of hyperhomocysteinaemia (HHcy) in different stages of chronic kidney disease (CKD) patients.
Study Design:
Cross-sectional, descriptive study. Place and Duration of the Study: Department of Chemical Pathology, Indus Hospital and Health Network Karachi, Pakistan, from July to December 2022.
Methodology:
Blood samples of 100 known CKD patients were collected for this study. The estimated glomerular filtration rate (eGFR) was calculated from the CKD-EPI calculator for CKD staging. Plasma homocysteine (Hcy) and serum creatinine concentrations were analysed on Abbott Alinity I and C analyzers, respectively. The SPSS was used for data compilation and analysis. Descriptive statistics were calculated. The association of HHcy with CKD and other variables was assessed using the Chi-square test as appropriate. A p-value of ≤0.05 was considered as significant.
Results:
Out of total 100, 52% males and 48% females known CKD patients were included in the study. The mean age of the patients was 50.62 ± 16.29 years. The median eGFR, serum creatinine, and Homocysteine were 18 ml/min/1.73m2, 3.48mg/dl, and 20.07 μmol/l, respectively. The percentage of CKD patients in each stage was 7% in stage 3a, 18% in stage 3b, 30% in stage 4, and 45% in stage 5. HHcy was observed in 79% of the CKD patients and among them 7.6% patients were in stage 3a, 19.0% in stage 3b, 31.6% in stage 4, and 41.8 % in stage 5.
Conclusion:
Patients with CKD were found to have HHcy indicating a very high level of prevalence in CKD patients, especially in the late stages. Hence, Hcy can be considered as a predictor of advancing disease. Timely interventions are required to prevent future adverse outcomes and improve the quality of life in CKD patients. However, a significant association was not seen between Hcy concentration and eGFR stages in the current study.
Key Words:
Hyperhomocysteinaemia, Estimated glomerular filtration rate, CKD-EPI calculator, Mortality, End-stage renal disease, Cardiovascular disease.
Related Concept Videos
Hormonal Regulation
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Nephrons
Kidney Structure

